Form 4/A for ANVS Annovis Bio, Inc.
Accepted 2023-11-22 00:00:00 ET · period of report 2023-11-20 · accession 0001104659-23-120769 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-11-22 | 2023-11-20 | ANVS | White Mark K. | Dir | A - Grant | $6.10 | +1,990 | 61.2K | +3% | +$12.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-20 | A | A | 1,990 | $6.10 | 61,167 | D | — | — |